Exalenz Bioscience Ltd.

Overview

The BreathID System is a revolutionary platform capable of assessing a range of liver and gastrointestinal disorders via molecular analysis of the patient’s exhaled breath. The system is the only breath-testing technology that provides continuous, automatic and real-time patient monitoring and data analysis. BreathID uses a clinically proven, sophisticated laser-like light source to pinpoint real-time changes in 13C/12C isotope ratios at an accuracy level of single parts per million. It is a paradigm change in the way liver and GI disorders are assessed and managed. Covered by more than 60 patents and patent applications worldwide, the BreathID system is one of the most versatile and advanced diagnostic platforms for hepatologists and gastroenterologists in today`s medical environment.

Benefits:

  • Assesses a wide range of Liver and GI disorders
  • Continuous, breath sampling
  • Automatic on-line collection and analysis
  • No patient cooperation required
    Small unit fits in any setting
    Clinically proven

 


 
 
For the Exalenz BreathID helicobacter pylori site, go to the H. pylori site

 

Exalenz Technology Movie

Click to see Exalenz BreathID's Technology in Action

 

 

2010 Exalenz Bioscience Ltd. All Rights Reserved
Developed by Moonsite

Disclaimer: In the USA, The BreathID System is intended for use in the qualitative detection of H. pylori. It has an approved 510(K) and an approved NDA for the 13 C-urea Tablet and Citrica Powder . Other applications are limited by Federal (of United States) Law to Investigational Use only. In Europe: The BreathID System has a CE approval for assessing Helicobacter pylori, Liver Function, and Gastric Emptying Rate.